Senior Vice President Quality
Fellow, Regulatory Science
Director, Xavier Health
Sr. Manager, Informatics and Analytics
FDA, pharma and device came together for the first time in August of 2017 at the Xavier AI Summit to explore together how Artificial Intelligence can advance quality operations into the future...today. Art Czabaniuk (FDA Pharma Program III Division Director) stated at the end of the summit that “This is it. This is the future of quality.” Likewise, Cisco Vicenty (CDRH Case for Quality Program Manager) expressed that “AI has the potential to fill in the gaps we cannot get to in our current approach/paradigm.” Xavier formed two working teams through the August Summit to explore solutions for industry-wide adoption of AI in quality operations. Learn firsthand what the excitement is all about as the working team leaders share their insights on the following questions:
What is the missing piece of the puzzle that prevents us from making strides in our supply chain operations?
What are the three new concepts that are action provoking in a way that shifts our paradigm of how we approach our supply chain?
If you had to pick three solutions to share, which ones are they...and what are they?